Per- and Polyfluoroalkyl Substances (PFAS) in Consumer Products, 64890-64892 [2023-20332]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
64890
Federal Register / Vol. 88, No. 181 / Wednesday, September 20, 2023 / Notices
action process and further streamline
the USPTO’s service delivery processes.
The USPTO furnishes a courtesy
postcard to Patent Center e-Office
Action program users as a reminder
when there are available USPTO
communications that have not been
viewed or downloaded after a period of
time. With the transition, the USPTO
introduced a new option to receive the
courtesy postcard by email (e-postcards)
rather than by postal mail (postal
postcards). In view of the new option to
receive e-postcards, the USPTO
requested public comments on
eliminating the postal postcard for all
Patent Center e-Office Action program
users. The USPTO is now eliminating
the postal postcard as an option for all
Patent Center e-Office Action program
users.
DATES: The option to receive a courtesy
postal postcard under the Patent Center
e-Office Action program will no longer
be available as of October 20, 2023.
Patent Center e-Office Action program
users may manually opt in to receiving
e-postcards prior to that date. As of
October 20, 2023, e-postcards will be
the only option for the courtesy
postcard, and the USPTO will
automatically switch over any Patent
Center e-Office Action program users
who have not already opted in to
receiving e-postcards. The USPTO will
continue to mail postal postcards for
seven days after October 20, 2023 for
any unviewed correspondence in the
queue as of October 20, 2023 for those
program users who were receiving
postal postcards prior to that date.
FOR FURTHER INFORMATION CONTACT:
Eugenia A. Jones, Senior Legal Advisor,
Office of Patent Legal Administration, at
571–272–7727; or Kristie A. Mahone,
Senior Legal Advisor, Office of Patent
Legal Administration, at 571–272–9016;
or patentpractice@uspto.gov. For
technical questions, please contact the
Patent Electronic Business Center (EBC)
at 1–866–217–9197 (toll-free), 571–272–
4100 (local), or ebc@uspto.gov. The
Patent EBC is open from 6 a.m. to
midnight ET, Monday–Friday.
SUPPLEMENTARY INFORMATION: In April
2023, the USPTO migrated all
participants from the Private PAIR eOffice Action program to the Patent
Center e-Office Action program. The
USPTO informed the public of the
migration in advance. See Patent Center
Electronic Office Action Program, 88 FR
20138 (Apr. 5, 2023) (April 2023
Notice).
Under the current Patent Center eOffice Action program, users have the
option to receive either a courtesy postal
postcard through the United States
VerDate Sep<11>2014
16:38 Sep 19, 2023
Jkt 259001
Postal Service or a courtesy e-postcard
by email. Courtesy reminder postcards
are sent when none of the Office
communications listed in the email
notification have been viewed or
downloaded in Patent Center within
seven calendar days after the date of the
notification and at least one of the listed
Office communications requires the
applicant’s reply. In the April 2023
Notice, the USPTO requested comments
on eliminating the courtesy postal
postcard as an option. The USPTO
received one comment in response to
the request for comments. The
commenter did not express any views
on eliminating the postal postcard and
only made a general comment about
Patent Center.
The USPTO has determined that
maintaining postal postcards is not
necessary. Eliminating the postal
postcard will reduce paper waste and
mitigate the impact of potential postal
delays. Furthermore, exclusively using
e-postcards will enable the USPTO to
continue to furnish courtesy reminders
while more effectively streamlining
service delivery processes. Therefore,
the USPTO is eliminating the postal
postcard as an option for all Patent
Center e-Office Action program users.
Instead, the USPTO will send a courtesy
e-postcard notifying Patent Center eOffice Action program users if none of
the Office communications listed in the
email notification are viewed or
downloaded through Patent Center
within seven calendar days after the
date of the email notification and at
least one of the Office communications
requires an applicant’s reply. The
USPTO will email courtesy e-postcards
to the same email addresses assigned to
the Customer Number for the
correspondence address.
Participation in the Patent Center eOffice Action program will continue to
be optional. Additional information on
the Patent Center e-Office Action
Program is available at www.uspto.gov/
patents/apply/checking-applicationstatus/e-office-action-program.
Katherine K. Vidal,
Under Secretary of Commerce for Intellectual
Property and Director of the United States
Patent and Trademark Office.
[FR Doc. 2023–20351 Filed 9–19–23; 8:45 am]
BILLING CODE 3510–16–P
PO 00000
Frm 00010
Fmt 4703
Sfmt 4703
CONSUMER PRODUCT SAFETY
COMMISSION
[Docket No. CPSC–2023–0033]
Per- and Polyfluoroalkyl Substances
(PFAS) in Consumer Products
Consumer Product Safety
Commission.
ACTION: Notice of availability and
request for information.
AGENCY:
The Consumer Product Safety
Commission (Commission or CPSC) is
publishing this notice to request
information on per- and polyfluoroalkyl
substances (PFAS) used in commerce or
potentially used in consumer products,
potential exposures associated with the
use of PFAS in consumer products, and
potential human health effects
associated with exposures to PFAS from
their use in consumer products. This
notice also includes the availability
information of a related contractor
report.
SUMMARY:
Written comments must be
submitted by November 20, 2023.
ADDRESSES: You can submit comments,
identified by Docket No. CPSC–2023–
0033, by any of the following methods:
Electronic Submissions: Submit
electronic comments to
www.regulations.gov. Follow the
instructions for submitting comments.
Do not submit through this website:
confidential business information, trade
secret information, or other sensitive or
protected information that you do not
want to be available to the public. CPSC
typically does not accept comments
submitted by email, except as described
below.
Mail/Hand Delivery/Courier/
Confidential Written Submissions: CPSC
encourages you to submit electronic
comments by using
www.regulations.gov. You may,
however, submit comments by mail,
hand delivery, or courier to: Office of
the Secretary, Consumer Product Safety
Commission, 4330 East-West Highway,
Bethesda, MD 20814; telephone: (301)
504–7479.
Instructions: All submissions must
include the agency name and docket
number. CPSC may post all comments
without change, including any personal
identifiers, contact information, or other
personal information provided to
www.regulations.gov. If you wish to
submit confidential business
information, trade secret information, or
other sensitive or protected information
that you do not want to be available to
the public, you may submit such
comments by mail, hand delivery, or
DATES:
E:\FR\FM\20SEN1.SGM
20SEN1
Federal Register / Vol. 88, No. 181 / Wednesday, September 20, 2023 / Notices
courier, or you may email them to: cpscos@cpsc.gov.
Docket: For access to the docket to
read background documents or
comments received, go to
www.regulations.gov, and insert the
docket number, CPSC–2023–0033, into
the ‘‘Search’’ box, and follow the
prompts. The report (Characterizing
PFAS Chemistries, Sources, Uses, and
Regulatory Trends in U.S. and
International Markets) is available in the
docket, under ‘‘Supporting and Related
Material’’ on the Commission’s website
at https://www.cpsc.gov/content/CPSCPFAS-WhitePaper, and from the CPSC’s
Office of the Secretary.
FOR FURTHER INFORMATION CONTACT:
Charles Bevington, Directorate for
Health Sciences, U.S. Consumer Product
Safety Commission, 5 Research Place,
Rockville, MD 20850; telephone: (301)
987–2009; email: cbevington@cpsc.gov.
SUPPLEMENTARY INFORMATION:
lotter on DSK11XQN23PROD with NOTICES1
I. Background
PFAS are manufactured chemicals
that contain multiple fluorine atoms
attached to carbon chains. There is no
single, universally accepted definition
of PFAS or authoritative list of
substances, although some researchers
and organizations have published
preferred definitions or have generated
such lists. The U.S. Environmental
Protection Agency (EPA) and other data
sources indicate that there are
thousands of different PFAS that could
be registered on U.S. or global chemical
inventories and are potentially in
commerce, hundreds of PFAS with
reported use information from the U.S.
or international sources, and several
dozen PFAS that are more commonly
measured in consumer products, the
environment, or in people. PFAS have
a variety of applications, including in
non-stick cookware; water-repellent and
stain resistant clothing, carpets and
other fabrics; some cosmetics; some
firefighting foams; and common home
products such as cleaning supplies,
waxes, coatings, adhesives, paints, and
sealants. This Request for Information
concerns ‘‘consumer products’’ which
includes products used in or around the
home or school that are subject to CPSC
jurisdiction under the Consumer
Product Safety Act (CPSA), 15 U.S.C.
2051 et seq., Federal Hazardous
Substances Act, 15 U.S.C. 1261 et seq.,
and other statutes administered by
CPSC. Cosmetics, drugs, and pesticides
generally are not within CPSC’s
jurisdiction under the CPSA.
PFAS can move through the
environment, and they break down very
slowly. They are commonly referred to
VerDate Sep<11>2014
16:38 Sep 19, 2023
Jkt 259001
as ‘‘forever chemicals.’’ 1 Consumer
products containing PFAS contribute to
aggregate exposures through mediated
(e.g., ingestion of indoor dust and
inhalation of indoor air) and contact
(e.g., mouthing of products and direct
dermal transfer) exposure pathways.
Consumer products containing PFAS
also contribute to aggregate exposures
through releases to the environment
from manufacturing and processing of
PFAS and formulation and disposal of
consumer products containing PFAS
(e.g., ingestion of drinking water).
Currently in the United States, local
jurisdictions, states, and other federal
agencies, including the EPA, U.S. Food
and Drug Administration (FDA), and
U.S. Department of Agriculture are
studying PFAS occurrences, human
exposures, and health effects that are
largely associated with environmental
exposures (e.g., contaminated drinking
water, food chain). In March 2023, the
White House Office of Science and
Technology Policy (OSTP) released a
PFAS Report informed by a Request for
Information and developed in
collaboration with many federal
agencies.2 That report provides a
comprehensive and recent summary of
known data and research gaps in four
areas: removal, destruction, or
degradation of PFAS, safer alternatives,
source and pathways of exposure, and
toxicity. This request for information by
CPSC is solely focused on potential use
or presence of PFAS in consumer
products, potential human exposures
associated with consumer product use,
and potential adverse human health
effects associated with consumer
product use.
CPSC contracted with RTI
International (Contract No. GS–00F–
354CA, Order No. 61320622F0078) to
complete an overview of PFAS with a
focus on PFAS that are potentially used
or present in consumer products. The
main objectives of the contract were to
(1) broadly characterize PFAS and
identify the uses and applications of
PFAS in consumer products, identify
significant individual PFAS with known
or potential consumer product
applications, and identify trends
associated with production and use of
PFAS in consumer products; (2) identify
international, federal, state, and local
1 PFAS are persistent in the environment and can
bioaccumulate in organisms. There is variability in
the persistence of different PFAS in various
environmental media and biological matrices.
2 The report (Per- and Polyfluoroalkyl Substances
(PFAS) Report | A Report by the Joint Subcommittee
on Environment, Innovation, and Public Health) is
available at https://www.whitehouse.gov/wpcontent/uploads/2023/03/OSTP-March-2023-PFASReport.pdf.
PO 00000
Frm 00011
Fmt 4703
Sfmt 4703
64891
regulations or restrictions for individual
or grouped PFAS; and (3) summarize
recent hazard (toxicity), exposure, or
risk assessments that have been
completed by authoritative bodies.
The completed RTI report,3 CPSC
staff’s statement on the report,4 and the
accompanying appendices and database
files 5 provide this information, describe
some data gaps, limitations, and
uncertainties, and identify possible next
steps.
The completed contractor report and
associated materials are available at:
https://www.regulations.gov under
docket number CPSC–2023–0033, on
the Commission’s website at https://
www.cpsc.gov/Research--Statistics/
Chemicals under the heading ‘‘Per- and
Polyfluoroalkyl Substances (PFAS’’),
and from the CPSC’s Office of the
Secretary at the location listed in the
ADDRESSES section of this notice.
This request for information (RFI)
seeks input from the public on PFAS
and potential uses or presence of PFAS
in consumer products, potential human
exposures associated with consumer
product use, and potential adverse
human health effects associated with
consumer product use. This RFI does
not constitute or propose regulatory
action, but rather is intended to inform
the Commission and the public.
II. Information Requested
CPSC is requesting information from
all stakeholders such as consumers,
manufacturers and importers,
government agencies, non-governmental
organizations, and researchers. Please
provide information focused on
consumer products and with
consideration for the information
already available to CPSC in the
contract report and associated
supporting files. The contractor report is
not a risk assessment and did not
identify all potential data sources that
could be used for risk assessment.
CPSC is particularly requesting
information on PFAS and potential use
or presence of PFAS in consumer
products, potential human exposures to
3 The report (Characterizing PFAS Chemistries,
Sources, Uses, and Regulatory Trends in U.S. and
International Markets) is available in the docket and
at https://www.cpsc.gov/content/CPSC-PFASWhitePaper.
4 The statement (CPSC Staff Statement on:
Characterizing PFAS Chemistries, Sources, Uses,
and Regulatory Trends in the U.S. and International
Markets) is available in the docket and at https://
www.cpsc.gov/content/PFAS-Market-Use-CoverMemo.
5 The file names and descriptions of appendices
and databases contained in supporting files are
described in CPSC Staff’s Statement. Appendices
and supporting files are available in the docket and
at https://www.cpsc.gov/Research--Statistics/
Chemicals.
E:\FR\FM\20SEN1.SGM
20SEN1
64892
Federal Register / Vol. 88, No. 181 / Wednesday, September 20, 2023 / Notices
PFAS associated with consumer product
use including information about
potentially highly exposed population
groups, and potential adverse human
health effects informed by toxicological
data sources. The Commission seeks
comment on all significant aspects of
this issue, including but not limited to
the following questions.
lotter on DSK11XQN23PROD with NOTICES1
Use or Potential Use of PFAS in
Consumer Products
1. Please provide information about
the definition of PFAS, including which
chemical substances should be
considered a perfluoroalkyl or
polyfluoroalkyl substance, which
chemical substances should be excluded
from consideration as a PFAS, and
which PFAS are considered in
commerce.
2. Please identify specific PFAS
potentially used or present in consumer
products that are not already included
in the contract report and related
supporting files. For each PFAS
chemical identified, specify relevant
consumer product(s) and/or use
categories.
3. Please provide information about
which specific PFAS the CPSC should
prioritize in assessments of potential
uses or presence of PFAS in consumer
products.
4. Please provide information about
which specific consumer products CPSC
should prioritize in assessments of
potential uses or presence of PFAS.
5. Please provide information about
consumer products or materials used in
consumer products that may be sources
of PFAS.
5a. For intentional uses of PFAS,
please provide information on:
Chemical identity and physical form
(solid, liquid, gas, semi-solid);
Functional purpose of the PFAS; and
measurements or estimates of levels/
concentration of PFAS used in
consumer products.
5b. Where PFAS may be present in
consumer products other than for
intentional, functional uses (such as
manufacturing or environmental
contaminants), please provide
information on sources of contaminants;
chemical identity and physical form;
degradation of substances or materials
in consumer products to PFAS; and
measurements or estimates of levels/
concentration of PFAS in consumer
products other than from intentional
uses.
VerDate Sep<11>2014
16:38 Sep 19, 2023
Jkt 259001
Potential Human Exposures to PFAS
Associated With Consumer Products
Use, Including Information About
Potentially Highly Exposed Population
Groups
6. Please provide information related
to the emission of PFAS from consumer
products into the indoor environment.
For example, studies or data that
estimate emission rates or mass transfer
parameters of PFAS chemicals from
consumer products or materials.
7. Please provide information related
to the migration of PFAS from consumer
products into saliva, gastrointestinal
fluid, or skin. For example, studies or
data that estimate migration rates into
biological fluids or surfaces based on
sustained contact time.
8. Please provide information about
the potential for exposure and risk from
presence of PFAS in consumer products
(including contact exposures from direct
use of consumer products and mediated
exposures such as through emission of
PFAS from products to surfaces, indoor
dust, or indoor air). Please provide:
8a. Data related to specific exposure
pathways from consumer product
sources and associated data or estimates
of occurrence of PFAS in environmental
media;
8b. Data on measurements or
estimates of PFAS intake, uptake,
clearance, half-life, or occurrence in
people (biomonitoring); and
8c. Data on the relative source
contribution of consumer product(s) or
ingestion of indoor dust, or inhalation of
indoor air compared with other relevant
sources such as ingestion of drinking
water or ingestion of food associated
with estimates of aggregate exposures.
9. Please provide information about
population groups that may use certain
consumer products for a greater than
average magnitude, frequency, or
duration based on habits, practices, and
characteristics specific to that
population group.
Potential Adverse Human Health Effects
Informed by Toxicological Data
10. Please provide reports and
underlying data for data sources that
could inform whether individual PFAS
or subclasses or categories of PFAS have
potential for adverse human health
effects. This includes human or animal
studies that report the relationship
between known exposures and observed
effects. This also includes new approach
methodology studies such as in-vitro
assays or in-silico predictions that
report the relationship between known
exposures and observed biological
activities related to health effects.
11. Please provide information on
additional sources of data and other
PO 00000
Frm 00012
Fmt 4703
Sfmt 4703
information that CPSC should consider
that are not already included or
mentioned in the contract report and
associated data files.
If you wish to submit confidential
information in response to this RFI,
please follow the instructions in the
ADDRESSES section above.
Alberta E. Mills,
Secretary, Consumer Product Safety
Commission.
[FR Doc. 2023–20332 Filed 9–19–23; 8:45 am]
BILLING CODE 6355–01–P
DEPARTMENT OF DEFENSE
Department of the Army, U.S. Army
Corps of Engineers
Notice of Funding Availability for
Applications for Credit Assistance
Under the Corps Water Infrastructure
Financing Program
U.S. Army Corps of Engineers,
Department of Defense (DoD).
ACTION: Notice of funding availability.
AGENCY:
The Corps Water
Infrastructure Financing Program
(CWIFP) is the U.S. Army Corps of
Engineers’ (Corps) new credit assistance
program for non-federal dam safety
projects. Through the Consolidated
Appropriations Act of 2021, the
Infrastructure Investment and Jobs Act,
and the Consolidated Appropriations
Act of 2022, CWIFP has been provided
$81 million in budget authority. The
purpose of this Notice of Funding
Availability (NOFA) is to solicit
preliminary applications from
prospective borrowers seeking credit
assistance from the Corps under CWIFP.
The Corps will evaluate and select
projects using selection criteria as
further described in this NOFA.
DATES: The preliminary application
submittal period begins today and ends
at 11:59 p.m. Eastern Standard Time on
December 19, 2023.
ADDRESSES: Prospective borrowers
should submit all preliminary
applications (OMB Control Number
0710–0026) electronically via the Corps
online application portal, located at:
https://CWIFPapp.usace.army.mil. After
registering within the application portal,
prospective borrowers will be able to
securely provide all required
information for the preliminary
application. If a prospective borrower
has any questions or needs assistance,
they should contact CWIFP@
usace.army.mil.
FOR FURTHER INFORMATION CONTACT:
Nathan Campbell at 651–219–2963 or by
SUMMARY:
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 88, Number 181 (Wednesday, September 20, 2023)]
[Notices]
[Pages 64890-64892]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20332]
=======================================================================
-----------------------------------------------------------------------
CONSUMER PRODUCT SAFETY COMMISSION
[Docket No. CPSC-2023-0033]
Per- and Polyfluoroalkyl Substances (PFAS) in Consumer Products
AGENCY: Consumer Product Safety Commission.
ACTION: Notice of availability and request for information.
-----------------------------------------------------------------------
SUMMARY: The Consumer Product Safety Commission (Commission or CPSC) is
publishing this notice to request information on per- and
polyfluoroalkyl substances (PFAS) used in commerce or potentially used
in consumer products, potential exposures associated with the use of
PFAS in consumer products, and potential human health effects
associated with exposures to PFAS from their use in consumer products.
This notice also includes the availability information of a related
contractor report.
DATES: Written comments must be submitted by November 20, 2023.
ADDRESSES: You can submit comments, identified by Docket No. CPSC-2023-
0033, by any of the following methods:
Electronic Submissions: Submit electronic comments to
www.regulations.gov. Follow the instructions for submitting comments.
Do not submit through this website: confidential business information,
trade secret information, or other sensitive or protected information
that you do not want to be available to the public. CPSC typically does
not accept comments submitted by email, except as described below.
Mail/Hand Delivery/Courier/Confidential Written Submissions: CPSC
encourages you to submit electronic comments by using
www.regulations.gov. You may, however, submit comments by mail, hand
delivery, or courier to: Office of the Secretary, Consumer Product
Safety Commission, 4330 East-West Highway, Bethesda, MD 20814;
telephone: (301) 504-7479.
Instructions: All submissions must include the agency name and
docket number. CPSC may post all comments without change, including any
personal identifiers, contact information, or other personal
information provided to www.regulations.gov. If you wish to submit
confidential business information, trade secret information, or other
sensitive or protected information that you do not want to be available
to the public, you may submit such comments by mail, hand delivery, or
[[Page 64891]]
courier, or you may email them to: [email protected].
Docket: For access to the docket to read background documents or
comments received, go to www.regulations.gov, and insert the docket
number, CPSC-2023-0033, into the ``Search'' box, and follow the
prompts. The report (Characterizing PFAS Chemistries, Sources, Uses,
and Regulatory Trends in U.S. and International Markets) is available
in the docket, under ``Supporting and Related Material'' on the
Commission's website at https://www.cpsc.gov/content/CPSC-PFAS-WhitePaper, and from the CPSC's Office of the Secretary.
FOR FURTHER INFORMATION CONTACT: Charles Bevington, Directorate for
Health Sciences, U.S. Consumer Product Safety Commission, 5 Research
Place, Rockville, MD 20850; telephone: (301) 987-2009; email:
[email protected].
SUPPLEMENTARY INFORMATION:
I. Background
PFAS are manufactured chemicals that contain multiple fluorine
atoms attached to carbon chains. There is no single, universally
accepted definition of PFAS or authoritative list of substances,
although some researchers and organizations have published preferred
definitions or have generated such lists. The U.S. Environmental
Protection Agency (EPA) and other data sources indicate that there are
thousands of different PFAS that could be registered on U.S. or global
chemical inventories and are potentially in commerce, hundreds of PFAS
with reported use information from the U.S. or international sources,
and several dozen PFAS that are more commonly measured in consumer
products, the environment, or in people. PFAS have a variety of
applications, including in non-stick cookware; water-repellent and
stain resistant clothing, carpets and other fabrics; some cosmetics;
some firefighting foams; and common home products such as cleaning
supplies, waxes, coatings, adhesives, paints, and sealants. This
Request for Information concerns ``consumer products'' which includes
products used in or around the home or school that are subject to CPSC
jurisdiction under the Consumer Product Safety Act (CPSA), 15 U.S.C.
2051 et seq., Federal Hazardous Substances Act, 15 U.S.C. 1261 et seq.,
and other statutes administered by CPSC. Cosmetics, drugs, and
pesticides generally are not within CPSC's jurisdiction under the CPSA.
PFAS can move through the environment, and they break down very
slowly. They are commonly referred to as ``forever chemicals.'' \1\
Consumer products containing PFAS contribute to aggregate exposures
through mediated (e.g., ingestion of indoor dust and inhalation of
indoor air) and contact (e.g., mouthing of products and direct dermal
transfer) exposure pathways. Consumer products containing PFAS also
contribute to aggregate exposures through releases to the environment
from manufacturing and processing of PFAS and formulation and disposal
of consumer products containing PFAS (e.g., ingestion of drinking
water).
---------------------------------------------------------------------------
\1\ PFAS are persistent in the environment and can bioaccumulate
in organisms. There is variability in the persistence of different
PFAS in various environmental media and biological matrices.
---------------------------------------------------------------------------
Currently in the United States, local jurisdictions, states, and
other federal agencies, including the EPA, U.S. Food and Drug
Administration (FDA), and U.S. Department of Agriculture are studying
PFAS occurrences, human exposures, and health effects that are largely
associated with environmental exposures (e.g., contaminated drinking
water, food chain). In March 2023, the White House Office of Science
and Technology Policy (OSTP) released a PFAS Report informed by a
Request for Information and developed in collaboration with many
federal agencies.\2\ That report provides a comprehensive and recent
summary of known data and research gaps in four areas: removal,
destruction, or degradation of PFAS, safer alternatives, source and
pathways of exposure, and toxicity. This request for information by
CPSC is solely focused on potential use or presence of PFAS in consumer
products, potential human exposures associated with consumer product
use, and potential adverse human health effects associated with
consumer product use.
---------------------------------------------------------------------------
\2\ The report (Per- and Polyfluoroalkyl Substances (PFAS)
Report [bond] A Report by the Joint Subcommittee on Environment,
Innovation, and Public Health) is available at https://www.whitehouse.gov/wp-content/uploads/2023/03/OSTP-March-2023-PFAS-Report.pdf.
---------------------------------------------------------------------------
CPSC contracted with RTI International (Contract No. GS-00F-354CA,
Order No. 61320622F0078) to complete an overview of PFAS with a focus
on PFAS that are potentially used or present in consumer products. The
main objectives of the contract were to (1) broadly characterize PFAS
and identify the uses and applications of PFAS in consumer products,
identify significant individual PFAS with known or potential consumer
product applications, and identify trends associated with production
and use of PFAS in consumer products; (2) identify international,
federal, state, and local regulations or restrictions for individual or
grouped PFAS; and (3) summarize recent hazard (toxicity), exposure, or
risk assessments that have been completed by authoritative bodies.
The completed RTI report,\3\ CPSC staff's statement on the
report,\4\ and the accompanying appendices and database files \5\
provide this information, describe some data gaps, limitations, and
uncertainties, and identify possible next steps.
---------------------------------------------------------------------------
\3\ The report (Characterizing PFAS Chemistries, Sources, Uses,
and Regulatory Trends in U.S. and International Markets) is
available in the docket and at https://www.cpsc.gov/content/CPSC-PFAS-WhitePaper.
\4\ The statement (CPSC Staff Statement on: Characterizing PFAS
Chemistries, Sources, Uses, and Regulatory Trends in the U.S. and
International Markets) is available in the docket and at https://www.cpsc.gov/content/PFAS-Market-Use-Cover-Memo.
\5\ The file names and descriptions of appendices and databases
contained in supporting files are described in CPSC Staff's
Statement. Appendices and supporting files are available in the
docket and at https://www.cpsc.gov/Research--Statistics/Chemicals.
---------------------------------------------------------------------------
The completed contractor report and associated materials are
available at: https://www.regulations.gov under docket number CPSC-
2023-0033, on the Commission's website at https://www.cpsc.gov/Research--Statistics/Chemicals under the heading ``Per- and
Polyfluoroalkyl Substances (PFAS''), and from the CPSC's Office of the
Secretary at the location listed in the ADDRESSES section of this
notice.
This request for information (RFI) seeks input from the public on
PFAS and potential uses or presence of PFAS in consumer products,
potential human exposures associated with consumer product use, and
potential adverse human health effects associated with consumer product
use. This RFI does not constitute or propose regulatory action, but
rather is intended to inform the Commission and the public.
II. Information Requested
CPSC is requesting information from all stakeholders such as
consumers, manufacturers and importers, government agencies, non-
governmental organizations, and researchers. Please provide information
focused on consumer products and with consideration for the information
already available to CPSC in the contract report and associated
supporting files. The contractor report is not a risk assessment and
did not identify all potential data sources that could be used for risk
assessment.
CPSC is particularly requesting information on PFAS and potential
use or presence of PFAS in consumer products, potential human exposures
to
[[Page 64892]]
PFAS associated with consumer product use including information about
potentially highly exposed population groups, and potential adverse
human health effects informed by toxicological data sources. The
Commission seeks comment on all significant aspects of this issue,
including but not limited to the following questions.
Use or Potential Use of PFAS in Consumer Products
1. Please provide information about the definition of PFAS,
including which chemical substances should be considered a
perfluoroalkyl or polyfluoroalkyl substance, which chemical substances
should be excluded from consideration as a PFAS, and which PFAS are
considered in commerce.
2. Please identify specific PFAS potentially used or present in
consumer products that are not already included in the contract report
and related supporting files. For each PFAS chemical identified,
specify relevant consumer product(s) and/or use categories.
3. Please provide information about which specific PFAS the CPSC
should prioritize in assessments of potential uses or presence of PFAS
in consumer products.
4. Please provide information about which specific consumer
products CPSC should prioritize in assessments of potential uses or
presence of PFAS.
5. Please provide information about consumer products or materials
used in consumer products that may be sources of PFAS.
5a. For intentional uses of PFAS, please provide information on:
Chemical identity and physical form (solid, liquid, gas, semi-solid);
Functional purpose of the PFAS; and measurements or estimates of
levels/concentration of PFAS used in consumer products.
5b. Where PFAS may be present in consumer products other than for
intentional, functional uses (such as manufacturing or environmental
contaminants), please provide information on sources of contaminants;
chemical identity and physical form; degradation of substances or
materials in consumer products to PFAS; and measurements or estimates
of levels/concentration of PFAS in consumer products other than from
intentional uses.
Potential Human Exposures to PFAS Associated With Consumer Products
Use, Including Information About Potentially Highly Exposed Population
Groups
6. Please provide information related to the emission of PFAS from
consumer products into the indoor environment. For example, studies or
data that estimate emission rates or mass transfer parameters of PFAS
chemicals from consumer products or materials.
7. Please provide information related to the migration of PFAS from
consumer products into saliva, gastrointestinal fluid, or skin. For
example, studies or data that estimate migration rates into biological
fluids or surfaces based on sustained contact time.
8. Please provide information about the potential for exposure and
risk from presence of PFAS in consumer products (including contact
exposures from direct use of consumer products and mediated exposures
such as through emission of PFAS from products to surfaces, indoor
dust, or indoor air). Please provide:
8a. Data related to specific exposure pathways from consumer
product sources and associated data or estimates of occurrence of PFAS
in environmental media;
8b. Data on measurements or estimates of PFAS intake, uptake,
clearance, half-life, or occurrence in people (biomonitoring); and
8c. Data on the relative source contribution of consumer product(s)
or ingestion of indoor dust, or inhalation of indoor air compared with
other relevant sources such as ingestion of drinking water or ingestion
of food associated with estimates of aggregate exposures.
9. Please provide information about population groups that may use
certain consumer products for a greater than average magnitude,
frequency, or duration based on habits, practices, and characteristics
specific to that population group.
Potential Adverse Human Health Effects Informed by Toxicological Data
10. Please provide reports and underlying data for data sources
that could inform whether individual PFAS or subclasses or categories
of PFAS have potential for adverse human health effects. This includes
human or animal studies that report the relationship between known
exposures and observed effects. This also includes new approach
methodology studies such as in-vitro assays or in-silico predictions
that report the relationship between known exposures and observed
biological activities related to health effects.
11. Please provide information on additional sources of data and
other information that CPSC should consider that are not already
included or mentioned in the contract report and associated data files.
If you wish to submit confidential information in response to this
RFI, please follow the instructions in the ADDRESSES section above.
Alberta E. Mills,
Secretary, Consumer Product Safety Commission.
[FR Doc. 2023-20332 Filed 9-19-23; 8:45 am]
BILLING CODE 6355-01-P
